A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments
Latest Information Update: 03 Oct 2024
At a glance
- Drugs Atezolizumab (Primary) ; Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- Acronyms ATEZOGIST
- 25 Jul 2024 Planned End Date changed from 1 Jun 2026 to 1 Oct 2027.
- 25 Jul 2024 Planned primary completion date changed from 1 Jan 2025 to 1 Oct 2027.
- 28 Apr 2022 Planned primary completion date changed from 1 Dec 2025 to 1 Jan 2025.